Markus Wartmann

9.2k citations
90 papers · 7.7k · 3 hit papers · h-index 42

Impact in

Papers in

    • Microtubule and mitosis dynamics 20
    • Hippo pathway signaling and YAP/TAZ 5
    • Synthesis and biological activity 29
    • Advanced Synthetic Organic Chemistry 5
    • Synthesis and pharmacology of benzodiazepine derivatives 4

Markus Wartmann

90 papers receiving 7.3k citations

Markus Wartmann's Hit Papers

Discovery of WRN inhibitor HRO761 with synthetic lethality in MSI cancers 2024 · 79 citations
790+11+22Years since publication5001k1.5k

Peers

Markus Wartmann
Comparison fields: 5 of 101
  • Biochemistry 392
  • Cell Biology 730
  • Oncology 1.1k
  • Molecular Biology 2.9k
  • Organic Chemistry 1.3k
Replace Takao Yamori with:
Takao Yamori Japan
Charles D. Smith United States
Tatsuya Tamaoki Japan
Ronald L. Magolda United States
Li Sun China
David T. Dudley United States
John Robert White United States
Walter Robert Bishop United States
Andrew S. Kraft United States
Bo Yang China
Markus Wartmann relative to Takao Yamori Japan Takao Yamori's profile →
Citations per field
00.5×1.5×2.1×
Takao Yamori · 1×
Citations per year

Countries citing papers authored by Markus Wartmann

Since Specialization
Citations

This map shows the geographic impact of Markus Wartmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Wartmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Wartmann more than expected).

Fields of papers citing papers by Markus Wartmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Wartmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Wartmann. The network helps show where Markus Wartmann may publish in the future.

Co-authors

The 25 scholars most cited alongside Markus Wartmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Markus Wartmann Line = papers co-authored together Markus Wartmann links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 90 papers — load more, or switch the sort, to bring in the rest.

#Work
1
cPLA2 is phosphorylated and activated by MAP kinase
Hit paper breakdown →
19931689
2 2011423
3 2014389
4 1994304
5 2004284
6 1994245
7 2009199
8 1991192
9 2001171
10 2000167
11 1995156
12 1989147
13 2005146
14 2010137
15 2000132
16 2011113
17 2007104
18 2008104
19 2010104
20 1996103

About Markus Wartmann

Markus Wartmann is a scholar working on Cell Biology, Organic Chemistry, Oncology, Molecular Biology and Hematology, having authored 90 papers that have together received 7.7k indexed citations. Recurring topics across this work include Synthesis and biological activity (29 papers), Microtubule and mitosis dynamics (20 papers), Cancer Treatment and Pharmacology (19 papers), Protein Kinase Regulation and GTPase Signaling (8 papers), Chemical Synthesis and Analysis (5 papers), Hippo pathway signaling and YAP/TAZ (5 papers), Advanced Synthetic Organic Chemistry (5 papers) and Synthesis and pharmacology of benzodiazepine derivatives (4 papers). The work is most often cited by research in Biochemistry (392 citations), Cell Biology (730 citations), Oncology (1.1k citations), Molecular Biology (2.9k citations) and Organic Chemistry (1.3k citations). Markus Wartmann has collaborated with scholars based in Switzerland, United States and Germany. Frequent co-authors include Roger J. Davis, Lih‐Ling Lin, Alice Y. Lin, John L. Knopf, Karl‐Heinz Altmann, Terence O’Reilly, Doriano Fabbro, Pascal Furet, Jürgen Mestan and Giorgio Caravatti. Their work appears in journals such as Journal of Medicinal Chemistry, Cancer Research, Journal of Biological Chemistry, Angewandte Chemie International Edition and ChemMedChem.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact